We are live on
!
Find out more
RJA
Raymond James & Associates Portfolio holdings
AUM
$164B
1-Year Est. Return
33.91%
This Fund
S&P 500
This Quarter
Est. Return
+2.33%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$152B
AUM Growth
+$4.77B
(+3.2%)
Cap. Flow
+$2.89B
Cap. Flow
% of AUM
1.9%
Top 10 Holdings %
Top 10 Hldgs %
26.78%
Holding
4,133
New
185
Increased
1,882
Reduced
1,701
Closed
184
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$255M |
| 2 |
Apple
AAPL
|
+$184M |
| 3 |
NextEra Energy
NEE
|
+$153M |
| 4 |
Walmart Inc
WMT
|
+$141M |
| 5 |
Public Service Enterprise Group
PEG
|
+$119M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$157M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$110M |
| 3 |
NVIDIA
NVDA
|
+$90.1M |
| 4 |
Vistra
VST
|
+$72.2M |
| 5 |
Union Pacific
UNP
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.11% |
| 2 | Financials | 8.61% |
| 3 | Healthcare | 7.69% |
| 4 | Industrials | 6.49% |
| 5 | Consumer Discretionary | 5.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JNPR
1376
DELISTED
Juniper Networks
JNPR
| $6.81M | ﹤0.01% |
186,720
+46,637
| +33% | +$1.66M |
|
1377
Lloyds Banking Group
LYG
$88.5B
| $6.79M | ﹤0.01% |
2,487,006
+1,327,589
| +115% | +$3.56M |
|
1378
Vanguard Total International Bond ETF
BNDX
$82.9B
| $6.79M | ﹤0.01% |
139,471
+4,512
| +3% | +$220K |
|
1379
ALPS Sector Dividend Dogs ETF
SDOG
$1.44B
| $6.76M | ﹤0.01% |
128,003
-3,182
| -2% | -$169K |
|
1380
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.6B
| $6.76M | ﹤0.01% |
93,831
-2,112
| -2% | -$151K |
|
1381
FT Vest Growth-100 Buffer ETF March
QMAR
$578M
| $6.76M | ﹤0.01% |
241,521
+207,654
| +613% | +$5.57M |
|
1382
CTS Corp
CTS
$1.83B
| $6.72M | ﹤0.01% |
132,729
+47,149
| +55% | +$2.33M |
|
1383
Acadia Healthcare
ACHC
$2.9B
| $6.72M | ﹤0.01% |
99,493
-18,067
| -15% | -$1.26M |
|
1384
Sibanye-Stillwater
SBSW
$7.51B
| $6.72M | ﹤0.01% |
1,544,729
-319,860
| -17% | -$1.58M |
|
1385
Organon & Co
OGN
$3.58B
| $6.72M | ﹤0.01% |
324,479
-37,651
| -10% | -$748K |
|
1386
Principal Financial Group
PFG
$24.2B
| $6.7M | ﹤0.01% |
85,391
-2,450
| -3% | -$199K |
|
1387
Nuveen Quality Municipal Income Fund
NAD
$2.75B
| $6.7M | ﹤0.01% |
570,446
+107,582
| +23% | +$1.21M |
|
1388
GMO US Quality ETF
QLTY
$5.07B
| $6.7M | ﹤0.01% |
+215,839
| New | +$6.43M |
|
1389
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.26B
| $6.69M | ﹤0.01% |
282,379
-2,650
| -0.9% | -$62.6K |
|
|
ETRN
1390
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $6.68M | ﹤0.01% |
514,943
-340,054
| -40% | -$4.56M |
|
1391
iShares Convertible Bond ETF
ICVT
$7.44B
| $6.68M | ﹤0.01% |
84,999
-460
| -0.5% | -$36K |
|
1392
Euronet Worldwide
EEFT
$2.64B
| $6.67M | ﹤0.01% |
64,403
-1,310
| -2% | -$143K |
|
1393
Harbor Commodity All-Weather Strategy ETF
HGER
$3.95B
| $6.67M | ﹤0.01% |
296,312
+4,602
| +2% | +$105K |
|
1394
Enovix
ENVX
$1.05B
| $6.66M | ﹤0.01% |
492,257
-13,838
| -3% | -$116K |
|
1395
Carter's
CRI
$1.46B
| $6.64M | ﹤0.01% |
107,190
+21,358
| +25% | +$1.48M |
|
1396
Nuveen Core Equity Alpha Fund
JCE
$290M
| $6.64M | ﹤0.01% |
442,559
+7,985
| +2% | +$113K |
|
1397
iShares iBonds Dec 2026 Term Treasury ETF
IBTG
$2.21B
| $6.62M | ﹤0.01% |
292,384
+42,335
| +17% | +$956K |
|
1398
Zscaler
ZS
$28.9B
| $6.62M | ﹤0.01% |
34,456
+2,579
| +8% | +$459K |
|
1399
Skyworks Solutions
SWKS
$10.3B
| $6.62M | ﹤0.01% |
62,071
-10,774
| -15% | -$1.06M |
|
1400
Pacer Aristotle Pacific Floating Rate High Income ETF
FLRT
$670M
| $6.61M | ﹤0.01% |
139,060
+11,779
| +9% | +$562K |
|
Similar funds
RJFSA
PI
ECU
EAM
AA
SA
WPL
ECU
Raymond James & Associates's Q2 2024 Portfolio in Review
As of Q2 2024, Raymond James & Associates held 4,133 positions worth $152B, up 3.2% from $148B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Raymond James & Associates's Q2 2024 filing shows 185 new, 1,882 increased, 1,701 reduced and 184 closed positions. Its largest new stake was Solventum: 321,226 shares worth $17M. The largest sale was State Street Health Care Select Sector SPDR ETF, an estimated $157M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Raymond James & Associates's largest Q2 2024 buy was Solventum: 321,226 shares worth $17M.
- Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2024, an estimated $255M increase.
- Raymond James & Associates's biggest Q2 2024 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $157M.
- Raymond James & Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $110M.
- Raymond James & Associates's ten largest holdings make up 27% of its $152B portfolio in Q2 2024.
- Raymond James & Associates opened 185 new positions and closed 184 in Q2 2024.
- Raymond James & Associates's portfolio value rose 3.2% quarter-over-quarter to $152B.
Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.